The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

Catalyst Pharmaceuticals is to go back to the ... But the FDA has required a whole new set of clinical trial data, although it has tried to accelerate development by granting a Breakthrough ...

The CATALYST trial will take place across 12 sites in the Midlands after the company partnered with the University of Oxford and University Hospitals Birmingham. The CATALYST trial is a rapid ...

which is facing a case focused on Catalyst’s Firdapse patent that expires in 2037. In the Notice Letter in January 2023, Teva stated that it intended to market a generic version of Firdapse ...

Mpox, Oncology Therapies and AI Integration Positions GeoVax for Strong Momentum ATLANTA, GA - February 5, 2025 (NEWMEDIAWIRE ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - January ...

“The SPIE Catalyst Award, in its second year, celebrates organizations that make significant contributions to environmental sustainability,” announced SPIE. “Schott’s pioneering efforts in ...

Machine learning (ML) transforms the design of heterogeneous catalysts, traditionally driven by trial and error due to the complex interplay of components. BIFOLD ...